4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one, 95.0%, 1g

1-(6-((Benzyloxy)bis(4-methoxyphenyl)methyl)-4-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-5-hydroxytetrahydro-2H-pyran-3-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95%, 100mg

1,1,2,2-Tetrakis(4-(bromomethyl)phenyl)ethene, 98%, 250mg

3-Ethoxy-5-methylpyridine, 95+%, 1g

4,4-Difluoropiperidine, 97.0%, 10g

1,8-Bis(maleimido)-3,6-dioxaoctane>98.0%(HPLC)250mg

4-Chloro-3,5-dinitrobenzoic Acid>98.0%(T)250g

4-Bromo-5-methyl-1H-pyrazol-3-ylamine, 95.0%, 10g

4-Ethynyl-2-methylthiazole, 95.0%, 100mg

methyl 4-[(E)-(2-mercapto-4-oxo-1,3-thiazol-5(4H)-ylidene)methyl]benzoate, 95.0%, 1g

3,3,3-Trifluoro-2-(4-fluoro-1H-indol-3-yl)propanoic acid, 1g

(2E)-1-(3-bromophenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

1-Methyl L-Aspartate>98.0%(T)1g